CD4CD25Foxp3 regulatory T (Treg) cell-mediated immunosuppression has been implicated as a crucial mechanism of tumor immune cell escape in nonsmall cell lung cancer (NSCLC). However, little is known concerning the specific role of CD4CD25Foxp3 Treg cells in NSCLC. The aim of this study was to investigate the frequency of circulating CD4CD25Foxp3 Treg cells and their role in NSCLC. The frequencies of Treg, T helper (Th)1, Th2, and Th17 cells in peripheral blood were separately measured in 36 NSCLC patients and 20 healthy controls (HCs) using flow cytometry. Serum cytokine concentrations were determined using cytometric bead arrays. The frequencies of circulating CD4CD25 T cells and CD4CD25Foxp3 and CD4CD25Foxp3 Treg cells were significantly higher in advanced-stage NSCLC patients compared with patients with limited-stage NSCLC. The frequencies of circulating CD4CD25Foxp3 and CD4CD25Foxp3 Treg cells were negatively correlated with interleukin (IL)-17, but positively correlated with serum IL-10 levels. In addition, the Th17/CD4CD25Foxp3 Treg cell ratios were negatively correlated with serum cytokeratin 19 fragment (CYFRA 21-1) concentrations in patients with NSCLC. Moreover, coculturing CD4CD25Foxp3 Treg cells and CD14 monocytes resulted in a higher frequency of CD206CD14 M2-like monocytes compared with CD14 monocytes. Elevated circulating CD4CD25Foxp3 Treg cells may be involved in the pathogenesis of NSCLC.

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2018.2672DOI Listing

Publication Analysis

Top Keywords

cd4cd25foxp3 treg
24
treg cells
24
circulating cd4cd25foxp3
16
cd4cd25foxp3
10
cells
9
treg
9
elevated circulating
8
cd4cd25foxp3 regulatory
8
nonsmall cell
8
cell lung
8

Similar Publications

Background: The role of T cells in the pathogenesis of oral squamous cell carcinoma (OSCC) was clarified by examining the levels of differentiated CD4CD25FOXP3 T-regulatory cells (Treg cells) and CD4+IL17+ T helper 17 (Th17) cells in OSCC patients.

Methods: Flow cytometry was conducted to measure the proportions of Treg/Th17 cells in different sample groups to identify a proper maker indicative of the progression and prognosis of OSCC.

Results: The results showed that a higher Treg/Th17 ratio led to poorer prognosis.

View Article and Find Full Text PDF

CD4CD25Foxp3 regulatory T (Treg) cell-mediated immunosuppression has been implicated as a crucial mechanism of tumor immune cell escape in nonsmall cell lung cancer (NSCLC). However, little is known concerning the specific role of CD4CD25Foxp3 Treg cells in NSCLC. The aim of this study was to investigate the frequency of circulating CD4CD25Foxp3 Treg cells and their role in NSCLC.

View Article and Find Full Text PDF

Change in the Treg/Th17 cell imbalance in hepatocellular carcinoma patients and its clinical value.

Medicine (Baltimore)

August 2017

Department of Hepatology, Qilu Hospital of Shandong University, Jinan Department of Gastroenterology, Zibo Central Hospital, Zibo Institute of Hepatology, Shandong University, Jinan, China.

Recent studies have indicated that the T cell mediated immune response plays an important role in the pathogenesis of hepatitis B virus-associated hepatocellular carcinoma (HCC), but the underlying mechanism remains unclear. In this study, we found an imbalance in Treg/Th17 cells in peripheral blood mononuclear cells from HCC patients. The percentages of CD4CD25FOXP3 Treg cells and CD4IL-17 Th17 cells were significantly higher in HCC patients than in the controls.

View Article and Find Full Text PDF

Blinatumomab can induce a complete haematological remission in patients in 46.6% with relapsed/refractory B-precursor acute lymphoblastic leukemia (r/r ALL) resulting in a survival benefit when compared with chemotherapy. Only bone marrow blast counts before therapy have shown a weak prediction of response.

View Article and Find Full Text PDF

CD4+CD25+ T Regulatory Cells in Transplantation Tolerance: 25 Years On.

Transplantation

December 2016

1 Immune Tolerance Laboratory, University of New South Wales, Sydney, Australia. 2 Ingham Institute Liverpool Hospital, Sydney, Australia.

In the 1970s, the capacity of T cells to inhibit immunity and those from transplant tolerant hosts to transfer alloantigen-specific suppression to lymphopenic recipients was described. CD4 T suppressor cells that ex vivo reverted to effector cells were described in the 1980s. Their antigen-specific suppressor function could be preserved by stimulation by specific donor alloantigen and cytokines from activated lymphocytes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!